7, the project is Biogn's to carry through to clinicals, if it isn't already. Anavex is a supplier an, to me, by its removal, it means that some other company is now taking up the efforts to see that 2-73 is a part of the MS solution. Aanvex has done all it can.
If that weren't the case, then MS would still be part of the pipeline. Dr. M knows the value of 2-73 as an adjunct to the MS cause and will/has found a partner
News 
Market Data 
Discover 
